← Immunocore Holdings plc

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Revenue $23.7m $25.7m $30.1m $26.5m $143.7m $249.4m $310.2m $400.0m
Total Revenue $23.7m $25.7m $30.1m $26.5m $143.7m $238.7m $310.2m $400.0m
Total revenue from sale of therapies — — $0 $3.0m $116.8m — — —
Cost of Goods and Services Sold $17.7m $19.3m $22.6m $19.9m $454k $1.0m $2.7m $5.1m
Cost Of Revenue — — — — — $1.0m $2.7m $5.1m
Reconciled Cost Of Revenue — — — — — $1.0m $2.7m $5.1m
Gross Profit — — — — — $248.4m $307.5m $394.9m
Gross Profit (Calculated) $5.9m $6.4m $7.5m $6.6m $143.3m $237.7m $307.5m $394.9m
Research And Development — — — — — $163.5m $222.2m $274.9m
Operating expenses:
Operating Income (Loss) ($93.5m) ($118.3m) ($86.2m) ($135.2m) ($39.6m) ($59.6m) ($70.5m) ($45.4m)
Additional Financial Items
Depreciation Right of Use Assets — $2.5m $2.5m $1.5m $1.8m — — —
Finance Income $1.1m $1.5m $2.2m $47k $3.2m — — —
Foreign Currency Transaction Gain (Loss), before Tax — — — — — ($13.2m) ($3.4m) $2.2m
Impairment Loss Recognised In Profit Or Loss Intangible Assets Other Than Goodwill — $306k $0 $0 — — — —
Operating Lease Income — $185k $460k $108k $0 — — —
Profit Loss Before Tax ($88.2m) ($126.2m) ($87.4m) ($140.9m) ($44.1m) — — —
Profit Loss From Operating Activities ($93.5m) ($118.3m) ($86.2m) ($135.2m) ($39.6m) ($59.6m) ($70.5m) ($45.4m)
Product revenue, net — — $0 $0 $108.1m — — —
Pre-product revenue, net — — $0 $3.0m $8.7m — — —
Collaboration revenue — — $30.1m $23.5m $26.9m — — —
Loss before taxation ($88.2m) ($126.2m) ($87.4m) ($140.9m) ($44.1m) — — —
Income tax credit $16.5m $22.3m $13.3m $9.4m $2.9m — — —
Loss for the year ($71.6m) ($103.9m) ($74.1m) ($131.5m) ($41.2m) — — —
Exchange differences on translation of foreign operations $72k ($99k) $195k ($74k) ($3.2m) — — —
Diluted EPS — — — — — — ($1.02) ($0.71)
Diluted NI Availto Com Stockholders — — — — — ($55.3m) ($51.1m) ($35.5m)
Gain On Sale Of PPE — — — ($243k) $4k — — —
Gain On Sale Of Security — — — — $14.2m ($13.2m) ($3.4m) $2.2m
Interest Income — — — — — $18.0m $25.6m $16.5m
Interest Income Non Operating — — — — — $18.0m $25.6m $16.5m
Net Income From Continuing And Discontinued Operation — — — — — ($55.3m) ($51.1m) ($35.5m)
Net Income From Continuing Operation Net Minority Interest — — — — — ($55.3m) ($51.1m) ($35.5m)
Net Interest Income — — — — — $12.8m $6.8m $4.3m
Normalized EBITDA — — — — — ($38.5m) ($26.4m) ($5.9m)
Normalized Income — — — — — ($43.3m) ($47.8m) ($37.3m)
Reconciled Depreciation — — — — — $4.1m $4.2m $3.3m
Selling General And Administration — — — — — $144.5m $155.8m $165.4m
Special Income Charges — — — ($243k) $4k — — —
Tax Effect Of Unusual Items — — — — — ($1.2m) ($124k) $465k
Tax Provision — — — — — ($5.6m) ($1.9m) $16.4m
Tax Rate For Calcs — — — — — $0 $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest — — — — — ($60.9m) ($52.9m) ($19.1m)
Total other comprehensive (loss) / income for the year, net of tax $3.7m ($99k) $195k ($74k) ($3.2m) — — —
Total comprehensive loss for the year, net of tax ($67.9m) ($104.0m) ($73.9m) ($131.6m) ($44.4m) — — —
Total Unusual Items — — — — — ($13.2m) ($3.4m) $2.2m
Total Unusual Items Excluding Goodwill — — — — — ($13.2m) ($3.4m) $2.2m
Pre-Tax Income — — — — — ($60.9m) ($52.9m) ($19.1m)
Net Income Continuous Operations — — — — — ($55.3m) ($51.1m) ($35.5m)
Net Income (Loss) Attributable to Parent — — — — — ($55.3m) ($51.1m) ($35.5m)
Net Income Including Noncontrolling Interests — — — — — ($55.3m) ($51.1m) ($35.5m)
Earnings Per Share, Basic ($3.32) ($4.66) ($2.79) ($3.10) ($0.90) ($1.13) ($1.02) ($0.71)
Earnings Per Share, Diluted ($3.32) ($4.66) ($2.79) ($3.10) ($0.90) ($1.13) ($1.02) ($0.71)
Basic Earnings (Loss) Per Share ($3.32) ($4.66) ($2.79) ($3.10) ($0.90) ($1.13) ($1.02) ($0.71)
Common Stock, Dividends, Per Share, Declared — ($4.66) ($2.79) ($3.10) ($0.90) — $0.00 $0.00
Diluted Earnings (Loss) Per Share ($3.32) ($4.66) ($2.79) ($3.10) ($0.90) ($1.13) ($1.02) ($0.71)
Weighted Average Number of Shares Outstanding, Basic — — — — — 48.9m 50.0m 50.3m
Basic Average Shares — — — — — — $50.0m $50.3m
Diluted Average Shares — — — — — — $50.0m $50.3m
Weighted Average Number of Shares Outstanding, Diluted — — — — — 48.9m 50.0m 50.3m
Research and Development Expense — $100.0m $74.8m $73.2m $89.2m $163.5m $222.2m $274.9m
Research and development costs ($83.6m) ($100.0m) ($74.8m) ($73.2m) ($89.2m) — — —
Selling, General and Administrative Expense — — — — $93.7m $144.5m $155.8m $165.4m
Other Nonoperating Income (Expense) — — — — — ($897k) $14.2m $19.7m
Administrative Expense — $44.2m $45.7m $88.4m — — — —
Current Tax Expense (Income) — ($21.6m) ($12.4m) ($9.0m) ($1.4m) — — —
Deferred Tax Expense (Income) — ($686k) ($819k) ($453k) ($1.5m) — — —
Deferred Tax Expense (Income) Recognised In Profit Or Loss — $0 ($790k) ($484k) ($1.4m) — — —
Employee Benefits Expense — $39.0m $40.4m $66.5m $68.8m — — —
Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used — $33k $19k $0 — — — —
Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used — $486k $296k $0 — — — —
Finance Costs ($842k) $9.4m $3.4m $5.8m $7.7m — — —
Other Finance Cost — $2k $0 $0 — — — —
Other Operating Income Expense ($93.5m) $0 $109k $0 $0 ($55.7m) ($34.1m) ($6.9m)
Postemployment Benefit Expense Defined Contribution Plans — $1.2m $1.0m $1.0m $1.4m — — —
Cost of product revenue — — $0 $0 ($454k) — — —
Selling and administrative expenses — — ($45.7m) ($88.4m) ($93.7m) — — —
Non-operating expense — ($7.9m) ($1.2m) ($5.8m) ($4.5m) — — —
Interest Expense (non-operating) — — — — — $5.2m $18.8m $12.2m
Interest Expense — — — — — $5.2m $18.8m $12.2m
Interest Expense, Debt — — — — — — $18.8m $12.2m
Interest Expense On Lease Liabilities — $2.9m $2.4m $1.7m $1.8m — — —
Current Income Tax Expense (Benefit) — — — — — ($240k) $2.0m $1.6m
Income Tax Expense Continuing Operations — ($22.3m) ($13.3m) ($9.4m) ($2.9m) — — —
Net Non Operating Interest Income Expense — — — — — $12.8m $6.8m $4.3m
Operating Expense — — — — — $308.0m $377.9m $440.3m
Other Income Expense — — — — — ($14.1m) $10.8m $21.9m
Other Non Operating Income Expenses — — — — ($1.7m) ($897k) $14.2m $19.7m
Income Tax Expense (Benefit) — — — — — ($5.6m) ($1.9m) $16.4m
Total Expenses — — — — — $309.1m $380.7m $445.4m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.